Minimum Order Quantity | 10 Vial |
Strength | 40 mg |
Form | Injection |
Packaging Size | 10 ml |
Packaging Type | Vial |
Pack Size | INJ. 40 MG VIAL WITH WATER |
Country of origin | Made in India |
Also gives | PCD pharma franchise, Third Party Manufacturing, Export |
GIVPEP-40 Injection contains Pantoprazole Sodium equivalent to Pantoprazole (Anhydrous) 40mg, a proton pump inhibitor (PPI) used for the treatment of acid reflux, GERD, gastric ulcers, and Zollinger-Ellison syndrome. This pack also includes a 10ml FFS ampoule of Sodium Chloride Injection (0.9% w/v) for dilution and intravenous administration.
This formulation is manufactured in WHO-GMP, USFDA, and EUGMP-certified facilities, ensuring high efficacy, stability, and rapid onset of action for hospital and critical care use.
How Does It Work?
✅ Pantoprazole (40mg) – A proton pump inhibitor (PPI) that blocks acid production in the stomach, relieving heartburn, acidity, and ulcers.
✅ Sodium Chloride Injection (0.9% w/v, 10ml FFS Ampoule) – A sterile diluent for safe IV administration to ensure optimal absorption and stability.
Key Features & Benefits:
✅ Fast-Acting Acid Control – Rapid relief for severe acid reflux, GERD, and ulcers.
✅ IV Formulation for Hospital Use – Designed for critical care and post-surgical patients.
✅ Long-Lasting Acid Suppression – Provides 24-hour relief from excessive stomach acid.
✅ High Stability & Bioavailability – Ensures maximum absorption & therapeutic effect.
✅ Manufactured in WHO-GMP & USFDA-Approved Facilities – Ensuring international quality compliance.
✅ Ideal for Third-Party Manufacturing & PCD Pharma Franchise
Indications (Who Should Use It?)
🔹 Patients with GERD, severe acid reflux, or stomach ulcers
🔹 Post-surgical & ICU patients requiring acid suppression therapy
🔹 Individuals suffering from Zollinger-Ellison syndrome (excessive acid production)
🔹 Suitable for hospital supply, stockists, and PCD Pharma distributors
Side Effects (Minimal & Rare):
Mild headache or dizziness
Nausea, bloating, or constipation (temporary & rare)
Injection site reactions (extremely rare)
⚠️ Use only under medical supervision in pregnancy, liver disorders, and long-term therapy.
Why Choose Us?
✅ WHO-GMP Certified Manufacturer for Pantoprazole Injections
✅ Best Quality API for Maximum Bioavailability
✅ COA Testing & Batch Validation for Every Order
✅ Ready Stock Available for PCD Pharma & Third-Party Manufacturing
✅ Rapid Dispatch & Secure Packaging for Medical Supply Chains
Customers Looking For:
✔️ PCD Pharma Franchise for Pantoprazole Injections
✔️ Third-Party Manufacturing of Pantoprazole 40mg Injection
✔️ Best Injection for Acid Reflux & GERD
✔️ WHO-GMP Certified Pantoprazole Injection Manufacturer
✔️ Export-Ready Pantoprazole Injection Supplier
Minimum Order Quantity | 10 Box |
Strength | 200 mg |
Manufacturer | Stelon Biotech |
Packaging Size | 10x10 Tablets |
Packaging Type | Box |
Country of Origin | Made in India |
THENFIX-PLUS Tablets combine the synergistic antibacterial action of Cefixime 200 mg, a third-generation cephalosporin, with Ofloxacin 200 mg, a broad-spectrum fluoroquinolone. This powerful dual therapy is effective against a wide range of gram-positive and gram-negative bacterial infections, especially where mono-therapy may fail. Ideal for treating UTIs, respiratory tract infections, typhoid, and GI infections, THENFIX-PLUS is formulated for fast action and high patient compliance. Packaged in 10x10 Alu-Alu blister strips to ensure product safety and shelf stability. Perfect for PCD Pharma Franchise, third-party manufacturing, and export.
How THENFIX-PLUS Works:
Cefixime (200 mg): Inhibits bacterial cell wall synthesis, leading to cell lysis.
Ofloxacin (200 mg): Inhibits DNA gyrase and topoisomerase IV, blocking bacterial DNA replication.
Key Features:
Dual-action antibiotic therapy for enhanced clinical outcomes
Effective against resistant or mixed bacterial infections
Suitable for acute infections involving multiple organ systems
Alu-Alu packaging ensures moisture resistance and export readiness
Manufactured under WHO-GMP standards with strict quality protocols
Indications:
Lower and upper respiratory tract infections (bronchitis, sinusitis, pneumonia)
Urinary tract infections (UTIs) and pyelonephritis
Gastrointestinal and abdominal infections (typhoid, diarrhea)
Skin and soft tissue infections
ENT infections and mixed bacterial infections
Side Effects:
May include nausea, diarrhea, or headache. Rarely, allergic reactions or photosensitivity. Use only under a physician’s guidance.
Disclaimer:
This product information is based on validated clinical data and is intended for educational purposes only. Use must be directed by a registered healthcare provider.
Why Choose Biofield Pharma Pvt Ltd for Combination Antibiotic Tablet Manufacturing:
WHO-GMP-certified non-beta facility with specialized zones for cephalosporin and fluoroquinolone manufacturing
Use of DMF-grade Cefixime and Ofloxacin APIs with proven bioavailability and potency
Expertise in formulating dual-spectrum antibiotics with excellent stability and compatibility
Alu-Alu blister packing for enhanced shelf life, safety, and humidity protection
Each batch tested for assay, disintegration, microbial limits, dissolution, and cross-contamination control
Full regulatory support for private branding, institutional supply, and international exports
Customers Looking For:
Third-party manufacturing of Cefixime + Ofloxacin 200 mg tablets
Exporters sourcing WHO-GMP-certified dual antibiotic therapies
PCD Pharma Franchise partners for high-demand infectious disease management products
Physicians treating acute bacterial infections with broader coverage needs
Distributors and chemists dealing in cephalosporin-fluoroquinolone combinations